Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Malek

Showing results (201-210 of 225) with videos related to

Pageof 23
Sort By:
Transplantation|June 18, 2003
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibodyR Damaris Molano, Antonello Pileggi, Thierry Berney, et al.
Clinical and Experimental Immunology|May 29, 2013
Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled studyJ D Price, G Linder, W P Li, et al.
Mymensingh Medical Journal : MMJ|February 14, 2019
Relationship between HbA1c and Lipid Profile Seen in Bangladeshi Type 2 Diabetes Mellitus Patients Attending BIRDEM Hospital: A Cross-Sectional StudyA Begum, S R Irfan, M R Hoque, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr miceY J Rosenberg, T R Malek, D E Schaeffer, et al.
HIV Medicine|August 19, 2016
Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditionsE Lord, A J Stockdale, R Malek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2J Kaye, S Gillis, S B Mizel, et al.
Nature Immunology|April 22, 2022
Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signalingAlejandro Moro, Zhen Gao, Lily Wang, et al.
Science Signaling|December 21, 2017
Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD miceConnor J Dwyer, Allison L Bayer, Carmen Fotino, et al.
The Journal of Clinical Investigation|October 5, 2010
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammationTaylor H Schreiber, Dietlinde Wolf, Matthew S Tsai, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2010
Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodiesR Malek, A Y Chong, B C Lupsa, et al.
Pageof 23

Showing results (201-210 of 225) with videos related to

Sort By:
Pageof 23
Transplantation|June 18, 2003
Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibodyR Damaris Molano, Antonello Pileggi, Thierry Berney, et al.
Clinical and Experimental Immunology|May 29, 2013
Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled studyJ D Price, G Linder, W P Li, et al.
Mymensingh Medical Journal : MMJ|February 14, 2019
Relationship between HbA1c and Lipid Profile Seen in Bangladeshi Type 2 Diabetes Mellitus Patients Attending BIRDEM Hospital: A Cross-Sectional StudyA Begum, S R Irfan, M R Hoque, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Unusual expression of IL 2 receptors and both the c-myb and c-raf oncogenes in T cell lines and clones derived from autoimmune MRL-lpr/lpr miceY J Rosenberg, T R Malek, D E Schaeffer, et al.
HIV Medicine|August 19, 2016
Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditionsE Lord, A J Stockdale, R Malek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1984
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2J Kaye, S Gillis, S B Mizel, et al.
Nature Immunology|April 22, 2022
Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signalingAlejandro Moro, Zhen Gao, Lily Wang, et al.
Science Signaling|December 21, 2017
Altered homeostasis and development of regulatory T cell subsets represent an IL-2R-dependent risk for diabetes in NOD miceConnor J Dwyer, Allison L Bayer, Carmen Fotino, et al.
The Journal of Clinical Investigation|October 5, 2010
Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammationTaylor H Schreiber, Dietlinde Wolf, Matthew S Tsai, et al.
The Journal of Clinical Endocrinology and Metabolism|May 21, 2010
Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodiesR Malek, A Y Chong, B C Lupsa, et al.
Pageof 23